eISSN: 2345-2781  
Submitted: 03 Apr 2017

Accepted: 10 Aug 2017
First published online: 29 Aug 2017
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Abstract Page Views: 383
PDF Downloads: 283
Full Text Views: 0
J Renal Inj Prev. 2018;7(2):103-106.
doi: 10.15171/jrip.2018.24

Scopus id: 85044730395

Case Report

De novo minimal change disease after kidney transplantation

Amirhesam Alirezaei 1, Elham Zare 2 * , Mahmoud Parvin 3, Fatemeh Nili 4, Mahmood Bakhtiyari 5,6

1 Clinical Research Developement Center at Shahid Modarres Hospital, Department of Nephrology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Department of Internal Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of pathology, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Department of Pathology, Cancer Institute, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
5 Department of Community Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
6 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding author: Elham Zare, Email: Elhamzr56@gmail.com

Abstract

Post-transplant glomerular diseases (PTGN) have been documented frequently, although majority of them, are recurrences of primary diseases. In some cases, de novo glomerular diseases can develop in recipients. In this paper, a case of de novo minimal change disease (MCD) after non-related live donor kidney transplantation in a patient with a history of biopsy proven membranous nephropathy is described. A 25-year-old man with history of biopsy-proven idiopathic membranous glomerulopathy (MGN) who had been transplanted 3 weeks before referred to hospital, presented with peripheral edema and massive proteinuria. First kidney biopsy was compatible with acute cellular rejection with glomerulitis. The patient was treated with methylprednisolone. Panel reactive antibody (PRA) and C4d were negative. Anti- phospholipase A2 receptor (PLA2R) antibody was also negative. Another allograft biopsy was conducted and the result was highly suggestive of MCD. Thus final diagnosis was de novo MCD and proteinuria decreased successfully.

Implication for health policy/practice/research/medical education:

De novo minimal change disease after kidney transplantation in a 25 year old patient with history of biopsy proven membranous glomerulopathy (MGN) is described.

Please cite this paper as: Alirezaei AH, Zare E, Parvin M, Nili F, Bakhtiyari M. De novo minimal change disease after kidney transplantation. J Renal Inj Prev. 2018;7(2):103-106. DOI: 10.15171/jrip.2018.24.

First name
 
Last name
 
Email address
 
Comments
 
Security code